Scaling Clinical Diagnostic Testing to the Masses (Part 1)

The rising cost of health care has hit Americans differently depending on their economic status. There is no shortage of news stories covering the reality of  those with higher incomes having higher life expectancies than those in lower financial brackets. Healthcare services such as clinical diagnostic testing may be out of reach for those who could really use it. So what are some the things a company can do to make clinical diagnostic testing more accessible for everyone? How can an important medical test be affordable to all?

On this episode of Health & Life Sciences at the Edge, host Michelle Dawn Mooney talks with Intel Head of Business Innovation and Life Science Specialist Blake Harlan and SiPhox Chief Product Officer Mike Dubrovsky about clinical diagnostic testing, the way it is used, and the way its use can be improved.

“Clinical diagnostic testing is actually a major part of the [healthcare] system,” says Dubrovsky. “Seventy percent of all medical decisions require diagnostic tests. However, the way that it’s done now is very reactive, so the whole system is based on first the patient having symptoms and then they’re put through a series of tests to try to resolve the problem.” Harlan and Dubrovsky further mention how it’s easy for those in higher income brackets to get tested more often, as those types of tests cost much more than the ones for reactive patients who are presently experiencing symptoms.

“The way the healthcare system works now is it’s really set up to, for the person, once they get sick, to deal with that” says Dubrovsky. He points out how the system is primarily designed to treat reactive care. “The problem is that there is a massive rise in healthcare costs, accompanied with actually a decrease in life expectancy, at least in America”, where six out of ten Americans have at least one chronic disease. In a country that spends so much on healthcare research, Harlan and Dubrovsky think the country needs to shift its thinking and policies when it comes to the health of its citizens.

Learn more about network operations center solutions by connecting with Blake Harlan and Mike Dubrovsky on LinkedIn or visiting SiPhox or Intel Health and Life Sciences.

Subscribe to this channel on Apple PodcastsSpotify, and Google Podcasts to hear more from the Intel Network and Edge Solutions Group.

Follow us on social media for the latest updates in B2B!

Image

Latest

bioprocessing solutions
Benchmark Products Bioprocessing Solutions Provide Single-Use Solutions for Customers
April 26, 2024

Benchmark provides a new bioprocessing solution to maximize efficiency. This is a single-use system for pharma manufacturers for filling, mixing and single-use assemblies.

Read More
Interphex
Benchmark at Interphex 2024
April 26, 2024

Benchmark Products showcased their line of life science and pharmaceutical manufacturing products during Interphex in New York City April 2024.

Read More
cyber risk management in healthcare
Navigating Cyber Risk Management in Healthcare Means Handling the Small Alerts and Big Alarms
April 26, 2024

In an era where digital dependencies are integral to healthcare operations, cyber risk management in healthcare requires addressing the big events and attending to the small ones. This urgent need to address and mitigate cyber vulnerabilities was a key discussion point during a MarketScale Experts Talk discussion on continued cybersecurity threats in healthcare. The […]

Read More
healthcare cybersecurity
Segmentation in Healthcare Cybersecurity Boils Down to Securing the Network and Protecting Patients
April 26, 2024

As healthcare institutions increasingly digitize their operations, the vulnerability of their networks to cyber breaches has highlighted the urgent need for robust cybersecurity measures. A recent Experts Talk discussion on cybersecurity risks in healthcare explores the pivotal role of network segmentation in fortifying these efforts. With patient data and healthcare service continuity at stake, […]

Read More